• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TRIVIDIA HEALTH INC TRUE METRIX; SYSTEM, TEST BLOOD GLUCOSE, OVER THE COUNTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TRIVIDIA HEALTH INC TRUE METRIX; SYSTEM, TEST BLOOD GLUCOSE, OVER THE COUNTER Back to Search Results
Model Number STRIP, TRUE METRIX NFRS24/CS 50CT MG/DL
Device Problem Low Test Results (2458)
Patient Problem Presyncope (4410)
Event Date 08/08/2022
Event Type  malfunction  
Manufacturer Narrative
Internal report reference number: (b)(4).Meter and test strips were not returned for evaluation.Note: manufacturer contacted customer in a follow-up call on 18-aug-2022 to ensure that the initial concern was resolved - able to establish contact with customer who stated is comfortable with the glucose readings from the product.
 
Event Description
Consumer reported complaint for low blood glucose test results.The customer is concerned with test results from results obtained of 62 mg/dl am fasting.The customer¿s expected am fasting blood glucose test result is 120 mg/dl.Customer stated he had been feeling lightheaded at the time the result of 62 mg/dl was obtained and had some sips of his glucerna.Customer then tested using another device and obtained 78 mg/dl non-fasting and stated he felt much better.At the time of the call the customer feels well and did not report any symptoms.Medical attention is not reported as a result of the actual blood glucose results and reported symptoms.The customer was not using the proper testing technique.During the call, a blood test was performed by the customer non-fasting and produced test result of 208 mg/dl using true metrix meter.The product is stored according to specification in the dining room.The test strip lot manufacturer¿s expiration date is 02/20/2023; customer was unsure of open vial date but stated it was not longer than 4 months ago.The meter memory was not reviewed for previous test result history.
 
Manufacturer Narrative
Sections with additional information as of 27-sep-2022: meter was not returned for evaluation.Test strips were not returned for evaluation.Retention testing was performed using test strips from the same lot.Retention strip lot passed within specifications.Most likely underlying root cause: mlc-062: user had poor technique.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRUE METRIX
Type of Device
SYSTEM, TEST BLOOD GLUCOSE, OVER THE COUNTER
Manufacturer (Section D)
TRIVIDIA HEALTH INC
2400 nw 55th court
fort lauderdale FL 33309
Manufacturer Contact
karen devincent
2400 nw 55th court
fort lauderdale, FL 33309
MDR Report Key15348323
MDR Text Key305691855
Report Number1000113657-2022-00470
Device Sequence Number1
Product Code NBW
UDI-Device Identifier00021292007836
UDI-Public(01)00021292007836
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K140100
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Remedial Action Other
Type of Report Initial,Followup
Report Date 09/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/02/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/20/2023
Device Model NumberSTRIP, TRUE METRIX NFRS24/CS 50CT MG/DL
Device Catalogue NumberRE4H01-81
Device Lot NumberMY4452S
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Distributor Facility Aware Date08/08/2022
Date Manufacturer Received09/06/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-